• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990年至1999年期间纽约市一种高度耐药结核菌株的持续存在。

Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999.

作者信息

Munsiff Sonal S, Nivin Beth, Sacajiu Galit, Mathema Barun, Bifani Pablo, Kreiswirth Barry N

机构信息

Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, New York, New York 10013, USA.

出版信息

J Infect Dis. 2003 Aug 1;188(3):356-63. doi: 10.1086/376837. Epub 2003 Jul 18.

DOI:10.1086/376837
PMID:12870116
Abstract

One multidrug-resistant Mycobacterium tuberculosis (MDRTB) strain, strain W, caused several nosocomial outbreaks in New York City (NYC) during 1 January 1990-31 July 1993. We reviewed all MDRTB cases verified during 1 August 1993-31 December 1999 that had isolates with either this DNA pattern or a variant of this strain, and we compared them to the outbreak cases. Of 427 DNA-confirmed cases from 1990-1999, 161 (37%) were from 1 August 1993-31 December 1999; these 161 cases, from 56 hospitals and 2 correctional sites, constituted 28% of all MDRTB cases in NYC during this period. Compared with those from 1 January 1990-31 July 1993, patients from 1 August 1993-31 December 1999 were less likely to be infected with human immunodeficiency virus, to have been born in the United States, to be homeless, to have been incarcerated, and to have epidemiological links; 16% of patients had nosocomial- and 9% had community-exposure links. This strain was disseminated widely in the community during the outbreaks; postoutbreak cases likely represent reactivated disease among individuals infected during the outbreak periods in the community.

摘要

1990年1月1日至1993年7月31日期间,一株耐多药结核分枝杆菌(MDRTB)菌株W在纽约市(NYC)引发了几起医院感染暴发。我们回顾了1993年8月1日至1999年12月31日期间所有经DNA检测确诊的MDRTB病例,这些病例的分离株具有该DNA模式或该菌株的变体,并将它们与暴发病例进行比较。在1990 - 1999年427例经DNA确认的病例中,161例(37%)来自1993年8月1日至1999年12月31日;这161例病例来自56家医院和2个惩教场所,占该时期纽约市所有MDRTB病例的28%。与1990年1月1日至1993年7月31日的病例相比,1993年8月1日至1999年12月31日的患者感染人类免疫缺陷病毒的可能性较小,在美国出生的可能性较小,无家可归的可能性较小,被监禁的可能性较小,且有流行病学关联的可能性较小;16%的患者有医院感染关联,9%的患者有社区暴露关联。在暴发期间,该菌株在社区中广泛传播;暴发后病例可能代表在社区暴发期间感染的个体中重新激活的疾病。

相似文献

1
Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999.1990年至1999年期间纽约市一种高度耐药结核菌株的持续存在。
J Infect Dis. 2003 Aug 1;188(3):356-63. doi: 10.1086/376837. Epub 2003 Jul 18.
2
Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis.针对结核分枝杆菌多重耐药菌株W的多重聚合酶链反应检测法。
J Clin Microbiol. 1994 Jun;32(6):1542-6. doi: 10.1128/jcm.32.6.1542-1546.1994.
3
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes.多机构高耐药性肺结核暴发:流行病学与临床结局
JAMA. 1996 Oct 16;276(15):1229-35.
4
A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York.纽约市爆发了多重耐药性结核分枝杆菌疫情。
Int J Tuberc Lung Dis. 1997 Apr;1(2):115-21.
5
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.纽约市耐多药结核分枝杆菌克隆家族的起源与跨州传播
JAMA. 1996 Feb 14;275(6):452-7.
6
Molecular epidemiology of multidrug-resistant tuberculosis, New York City, 1995-1997.1995 - 1997年纽约市耐多药结核病的分子流行病学
Emerg Infect Dis. 2002 Nov;8(11):1230-8. doi: 10.3201/eid0811.020288.
7
Temporal trends and transmission patterns during the emergence of multidrug-resistant tuberculosis in New York City: a molecular epidemiologic assessment.纽约市耐多药结核病出现期间的时间趋势和传播模式:一项分子流行病学评估。
J Infect Dis. 1995 Jan;171(1):170-6. doi: 10.1093/infdis/171.1.170.
8
Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain.与耐多药W菌株相关的链霉素单耐药结核分枝杆菌的分子鉴定
Emerg Infect Dis. 2001 Sep-Oct;7(5):842-8. doi: 10.3201/eid0705.010512.
9
The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error.纽约市结核病的分子流行病学:医院内传播和实验室误差的重要性。
Tuber Lung Dis. 1996 Oct;77(5):407-13. doi: 10.1016/s0962-8479(96)90112-4.
10
Outbreak of multidrug-resistant tuberculosis at a hospital--New York City, 1991.1991年纽约市一家医院的耐多药结核病暴发
MMWR Morb Mortal Wkly Rep. 1993 Jun 11;42(22):427, 433-4.

引用本文的文献

1
Prevalence of Beijing Central Asian/Russian Cluster 94-32 among Multidrug-Resistant in Kazakhstan.哈萨克斯坦耐多药结核病患者中北京中亚/俄罗斯94-32簇的流行情况。
Antibiotics (Basel). 2023 Dec 20;13(1):9. doi: 10.3390/antibiotics13010009.
2
Preclinical Progress of Subunit and Live Attenuated Vaccines: A Review following the First in Human Efficacy Trial.亚单位疫苗和减毒活疫苗的临床前进展:首次人体疗效试验后的综述
Pharmaceutics. 2020 Sep 6;12(9):848. doi: 10.3390/pharmaceutics12090848.
3
A Mycobacterium tuberculosis Beijing strain persists at high rates and extends its geographic boundaries 20 years after importation.
结核分枝杆菌北京株在输入 20 年后仍保持高流行率,并扩大了其地理范围。
Sci Rep. 2019 Mar 18;9(1):4687. doi: 10.1038/s41598-019-40525-6.
4
First insights on the genetic diversity of MDR Mycobacterium tuberculosis in Lebanon.黎巴嫩耐多药结核分枝杆菌遗传多样性的初步研究。
BMC Infect Dis. 2018 Dec 29;18(1):710. doi: 10.1186/s12879-018-3626-3.
5
Immunotherapeutic effect of BCG-polysaccharide nucleic acid powder on Mycobacterium tuberculosis-infected mice using microneedle patches.卡介苗多糖核酸粉通过微针贴片对结核分枝杆菌感染小鼠的免疫治疗作用
Drug Deliv. 2017 Nov;24(1):1648-1653. doi: 10.1080/10717544.2017.1391892.
6
A quantitative and efficient approach to select MIRU-VNTR loci based on accumulation of the percentage differences of strains for discriminating divergent Mycobacterium tuberculosis sublineages.一种基于菌株百分比差异积累来选择MIRU-VNTR基因座的定量有效方法,用于区分不同的结核分枝杆菌亚谱系。
Emerg Microbes Infect. 2017 Jul 26;6(7):e68. doi: 10.1038/emi.2017.58.
7
Tuberculosis in Enclosed Populations.密闭人群中的结核病。
Microbiol Spectr. 2017 Mar;5(2). doi: 10.1128/microbiolspec.TNMI7-0041-2017.
8
Thioridazine: A Non-Antibiotic Drug Highly Effective, in Combination with First Line Anti-Tuberculosis Drugs, against Any Form of Antibiotic Resistance of Mycobacterium tuberculosis Due to Its Multi-Mechanisms of Action.硫利达嗪:一种非抗生素药物,由于其多作用机制,与一线抗结核药物联合使用时,对任何形式的结核分枝杆菌抗生素耐药性均具有高效。
Antibiotics (Basel). 2017 Jan 14;6(1):3. doi: 10.3390/antibiotics6010003.
9
Whole genome sequencing identifies circulating Beijing-lineage Mycobacterium tuberculosis strains in Guatemala and an associated urban outbreak.全基因组测序在危地马拉发现传播的北京家族结核分枝杆菌菌株及一起相关的城市疫情。
Tuberculosis (Edinb). 2015 Dec;95(6):810-816. doi: 10.1016/j.tube.2015.09.001. Epub 2015 Sep 28.
10
Epidemiologic Correlates of Pyrazinamide-Resistant Mycobacterium tuberculosis in New York City.纽约市耐吡嗪酰胺结核分枝杆菌的流行病学关联
Antimicrob Agents Chemother. 2015 Oct;59(10):6140-50. doi: 10.1128/AAC.00764-15. Epub 2015 Jul 20.